8:06 AM ET
8-K
Capital Raise
PDS Biotechnology Capital Raise of $3.9M
NantWorks exercised outstanding common stock warrants to purchase 17,699,115 shares of PDS Biotechnology at an exercise price of $0.22 per share. The transaction generated approximately $3.9 million in gross proceeds for the company. PDS Biotech intends to use the funds to advance its PDS0301 program toward a Phase 3 trial in metastatic colorectal cancer and for general corporate purposes.
- Value
- $3.9M
- Counterparty
- NantWorks